<DOC>
	<DOCNO>NCT02721550</DOCNO>
	<brief_summary>This perspective , multicenter , single arm , open label , Phase 2 study evaluate efficacy safety treatment CMNa combine preoperatie concurrent chemoradiotherapy patient locally advance squamous cell esophageal carcinoma . Analyses primary objective ( pathologic Complete Response ) do define protocol .</brief_summary>
	<brief_title>A Trial CMNa Combined With Preoperatie Concurrent Chemoradiotherapy Locally Advanced ESCC</brief_title>
	<detailed_description>The primary end ponit study pathological complete response.And primary hypothesis CMNa improve patholofical response rate thus improve OS、DFS . Assuming bilateral a=0.05 , statistical power 80 % .The total sample size 40 case .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>1 . Signed write informed consent prior study entry 2 . Patients ESCC thoracic segment resectable（T23，N01，M0） confirm image pathology cytology ; 3 . Patients tumor lesion objectively measure , length tumor : ≤8cm , width tumor : ≤5cm ; If tumor cross GEJ violate proximal stomach , tumor must include esophagus GEJ . The tumor le 2cm stomach 4 . Not infringe bronchial wall ; esophagustracheal fistula . 5. normal bone marrow reserve : ANCcount ≥1500/mm3 ; platelet count ≥100,000/mm3 , hemoglobin≥9g/dl 6. normal hepatic funcion : bilirubin level ≤1.5×ULN ; AST/ALT≤1.5×ULN 7. normal renal function : serum creatinine≤1.5mg/dl calculate creatinine clearance ≥60ml/min 8. normal cardiac function 9 . ECOG PS 0 1 10 . Expected lifetime≥3 month 11 . Subjects tumor tissue available relevant biomarker detection 1 . Female subject pregnancy lactation , subject fertility n't take effective contraception study . 2 . Any mental illness nervous system lesion ca n't tell treatment response clearly ( cerebrovascular accident sequela ) 3 . Any serious uncontrolled disease infection , severe heart , liver , kidney disease diabetes , ca n't complete treatment plan 4 . Patients malignant lesion , except curable skin cancer ( non melanoma skin cancer ) , carcinoma situ cervix serve disease cure 5 year 5 . Primary lesion multifocal 6 . Patients distant metastasis . A small amount stomach tumor violate GEJ distal esophageal . 7 . Patients obvious esophageal ulcer moderate pain chestback symptom esophageal perforation 8. receive anticancer treatment esophageal cancer group , include surgery , radiotherapy , chemotherapy ( induction chemotherapy group great equal two cycle ) . 9 . Cervical esophageal cancer confirm iconography 10 . Not esophageal squamous carcinoma confirm pathology cytology 11 . History active hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>